Answers are grounded in this paper and cite their sources.
Bioengineering enhances functionalization of rubromycins, suggesting new antibody-drug conjugates could be developed.
RaABS allowed the azide functionalization of rubromycins, thereby setting the stage for bioorthogonal click chemistry that can be employed in the future, for example, for the generation of antibody-drug conjugates.
No takes yet. Share an insight, caveat, or question.
(23810586) et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: